help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sirvent, J. M.
Right arrow Articles by Bonet, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sirvent, J. M.
Right arrow Articles by Bonet, A.

Am. J. Respir. Crit. Care Med., Vol 155, No. 5, 05 1997, 1729-1734.

Protective effect of intravenously administered cefuroxime against nosocomial pneumonia in patients with structural coma

JM Sirvent, A Torres, M El-Ebiary, P Castro, J de Batlle and A Bonet
Departament de Medicina, Universitat de Barcelona, Spain.

In comatose patients admitted to an ICU, particularly those with head injury, the incidence of early onset pneumonia is exceedingly high. We performed an open, prospective, randomized, and controlled clinical trial aiming at the reduction of the incidence of ventilator-associated pneumonia in head-injured patients and patients with stroke requiring mechanical ventilation. One hundred patients were included because of head injury or coma caused by medical stroke and with Glasgow coma scores < or = 12 and mechanical ventilation > 72 h. Patients eligible for the study (n = 50) received cefuroxime intravenously (two 1,500-mg doses 12 h apart after intubation) (the cefuroxime group) and 50 patients not receiving cefuroxime formed the control group. In the former group patients did not receive any other antibiotics before the end-point determination, whereas in the latter, 17 patients received prophylactic antibiotics as prescribed by the attending physician. The global incidence of microbiologically confirmed pneumonia was 37% (n = 37); 12 (24%) belonged to the cefuroxime group, and 25 (50%) belonged to the control group (p = 0.007). Early-onset pneumonia accounted for 70% of all the pneumonia episodes (n = 26), eight (67%) belonging to the cefuroxime group, and 18 (72%) belonging to the control group (p = 0.02). In the control group, four of 17 (23%) patients receiving prior antibiotics developed pneumonia, whereas 21 of 33 (64%) patients who did not receive antibiotics developed pneumonia (p = 0.016). The multivariate analysis revealed that the duration of mechanical ventilation (per each day) was an independent risk factor significantly associated to the development of pneumonia. Furthermore, the use of cefuroxime and/or prior antibiotics in the control group, before the pneumonia episode, had a protective effect against its development. No differences were found with regard to mortality and morbidity when comparing the study population with the control group. Nevertheless, when comparing patients with pneumonia (from both study and control groups) with those without it, there was a decrease in total hospital stay (35 +/- 13 versus 25 +/- 14 d, p = 0.048) and ICU stay (20 +/- 11 versus 11 +/- 7 d, p = 0.001). The study demonstrated that the administration of two single high doses 1,500 mg each of cefuroxime after the intubation of patients comatose because of head injury or medical stroke is an effective prophylactic strategy to decrease the incidence of ventilator-associated pneumonia.


This article has been cited by other articles:


Home page
ChestHome page
A. Pobo, T. Lisboa, A. Rodriguez, R. Sole, M. Magret, S. Trefler, F. Gomez, J. Rello, and for the RASPALL Study Investigators
A Randomized Trial of Dental Brushing for Preventing Ventilator-Associated Pneumonia
Chest, August 1, 2009; 136(2): 433 - 439.
[Abstract] [Full Text] [PDF]


Home page
ACCP Crit Care Med Brd RevHome page
M. S. Niederman
Severe Pneumonia
ACCP Crit Care Med Brd Rev, January 1, 2009; 20(0): 485 - 506.
[Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
R. G. Masterton, A. Galloway, G. French, M. Street, J. Armstrong, E. Brown, J. Cleverley, P. Dilworth, C. Fry, A. D. Gascoigne, et al.
Guidelines for the management of hospital-acquired pneumonia in the UK: Report of the Working Party on Hospital-Acquired Pneumonia of the British Society for Antimicrobial Chemotherapy
J. Antimicrob. Chemother., July 1, 2008; 62(1): 5 - 34.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
L. Lorente, S. Blot, and J. Rello
Evidence on measures for the prevention of ventilator-associated pneumonia
Eur. Respir. J., December 1, 2007; 30(6): 1193 - 1207.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
S. Nseir, C. Di Pompeo, E. Jozefowicz, B. Cavestri, H. Brisson, M. Nyunga, S. Soubrier, and A. Durocher
Relationship between tracheotomy and ventilator-associated pneumonia: a case control study
Eur. Respir. J., August 1, 2007; 30(2): 314 - 320.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
K Thorburn, S Harigopal, V Reddy, N Taylor, and H K F van Saene
High incidence of pulmonary bacterial co-infection in children with severe respiratory syncytial virus (RSV) bronchiolitis
Thorax, July 1, 2006; 61(7): 611 - 615.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
J D Hunter
Ventilator associated pneumonia.
Postgrad. Med. J., March 1, 2006; 82(965): 172 - 178.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia
Am. J. Respir. Crit. Care Med., February 15, 2005; 171(4): 388 - 416.
[Full Text] [PDF]


Home page
Nutr Clin PractHome page
C. M. Parker and D. K. Heyland
Aspiration and the Risk of Ventilator-Associated Pneumonia
Nutr Clin Pract, December 1, 2004; 19(6): 597 - 609.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
J. Rello and E. Diaz
Ventilator-Associated Pneumonia, Percutaneous Tracheostomy, and Antimicrobial Prophylaxis
Chest, October 1, 2004; 126(4): 1382 - 1383.
[Full Text] [PDF]


Home page
ANN INTERN MEDHome page
H. R. Collard, S. Saint, and M. A. Matthay
Prevention of Ventilator-Associated Pneumonia: An Evidence-Based Systematic Review
Ann Intern Med, March 18, 2003; 138(6): 494 - 501.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
W. A. Krueger, F.-P. Lenhart, G. Neeser, G. Ruckdeschel, H. Schreckhase, H.-J. Eissner, H. Forst, J. Eckart, K. Peter, and K. E. Unertl
Influence of Combined Intravenous and Topical Antibiotic Prophylaxis on the Incidence of Infections, Organ Dysfunctions, and Mortality in Critically Ill Surgical Patients: A Prospective, Stratified, Randomized, Double-Blind, Placebo-controlled Clinical Trial
Am. J. Respir. Crit. Care Med., October 15, 2002; 166(8): 1029 - 1037.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. Chastre and J.-Y. Fagon
Ventilator-associated Pneumonia
Am. J. Respir. Crit. Care Med., April 1, 2002; 165(7): 867 - 903.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
J. Rello, J. A. Paiva, J. Baraibar, F. Barcenilla, M. Bodi, D. Castander, H. Correa, E. Diaz, J. Garnacho, M. Llorio, et al.
International Conference for the Development of Consensus on the Diagnosis and Treatment of Ventilator-Associated Pneumonia
Chest, September 1, 2001; 120(3): 955 - 970.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
D. C. J. J. BERGMANS, M. J. M. BONTEN, C. A. GAILLARD, J. C. PALING, S. van der GEEST, F. H. van TIEL, A. J. BEYSENS, P. W. de LEEUW, and E. E. STOBBERINGH
Prevention of Ventilator-associated Pneumonia by Oral Decontamination . A Prospective, Randomized, Double-blind, Placebo-controlled Study
Am. J. Respir. Crit. Care Med., August 1, 2001; 164(3): 382 - 388.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
Members of the Task Force:, E. Bouza, C. Brun-Buisson, J. Chastre, S. Ewig, J-Y. Fagon, C.H. Marquette, P. Munoz, M.S. Niederman, L. Papazian, et al.
Ventilator-associated pneumonia: European Task Force on ventilator-associated pneumonia Chairmen of the Task Force: A. Torres and J. Carlet
Eur. Respir. J., May 1, 2001; 17(5): 1034 - 1045.
[Full Text] [PDF]


Home page
ANN INTERN MEDHome page
M. H. Kollef and V. J. Fraser
Antibiotic Resistance in the Intensive Care Unit
Ann Intern Med, February 20, 2001; 134(4): 298 - 314.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
J. P. Lynch III
Hospital-Acquired Pneumonia : Risk Factors, Microbiology, and Treatment
Chest, February 1, 2001; 119 (2009): 373S - 384S.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
M. J. M. Bonten, B. J. Kullberg, R. van Dalen, A. R. J. Girbes, I. M. Hoepelman, W. Hustinx, J. W. M. van der Meer, P. Speelman, E. E. Stobberingh, H. A. Verbrugh, et al.
Selective digestive decontamination in patients in intensive care
J. Antimicrob. Chemother., September 1, 2000; 46(3): 351 - 362.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
R. G. Wunderink
Prevention of Ventilator-Associated Pneumonia : Does One Size Fit All?
Chest, November 1, 1999; 116(5): 1155 - 1156.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. RELLO, E. DIAZ, M. ROQUE, and J. VALLÉS
Risk Factors for Developing Pneumonia within 48 Hours of Intubation
Am. J. Respir. Crit. Care Med., June 1, 1999; 159(6): 1742 - 1746.
[Abstract] [Full Text]


Home page
ThoraxHome page
J.-L. Vincent
Prevention of nosocomial bacterial pneumonia
Thorax, June 1, 1999; 54(6): 544 - 549.
[Full Text]


Home page
NEJMHome page
M. H. Kollef
The Prevention of Ventilator-Associated Pneumonia
N. Engl. J. Med., February 25, 1999; 340(8): 627 - 634.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. EWIG, A. TORRES, M. EL-EBIARY, N. FÁBREGAS, C. HERNÁNDEZ, J. GONZÁLEZ, J. M. NICOLÁS, and L. SOTO
Bacterial Colonization Patterns in Mechanically Ventilated Patients with Traumatic and Medical Head Injury . Incidence, Risk Factors, and Association with Ventilator-associated Pneumonia
Am. J. Respir. Crit. Care Med., January 1, 1999; 159(1): 188 - 198.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1997 American Thoracic Society
  Work-Life